Original Research
Published on 26 Nov 2024
A novel molecular classification system based on the molecular feature score identifies patients sensitive to immune therapy and target therapy
in Cancer Immunity and Immunotherapy
- 380 views
Original Research
Published on 26 Nov 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 26 Nov 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 26 Nov 2024
in Cancer Immunity and Immunotherapy
Case Report
Published on 26 Nov 2024
in Cancer Immunity and Immunotherapy
Clinical Trial
Published on 26 Nov 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 26 Nov 2024
in Cancer Immunity and Immunotherapy
Review
Published on 26 Nov 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 26 Nov 2024
in Cancer Immunity and Immunotherapy
Original Research
Published on 26 Nov 2024
in Cancer Immunity and Immunotherapy
Correction
Published on 26 Nov 2024
in Cancer Immunity and Immunotherapy
Mini Review
Published on 26 Nov 2024
in Cancer Immunity and Immunotherapy
Case Report
Published on 26 Nov 2024
in Cancer Immunity and Immunotherapy
Review
Published on 26 Nov 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 25 Nov 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 25 Nov 2024
in Cancer Immunity and Immunotherapy
Opinion
Accepted on 25 Nov 2024
in Cancer Immunity and Immunotherapy